Clinical Trial

Rehabilitation of Taste and Smell Disorders Associated With Chemotherapy Using Aromatherapy

Study acronym: AGORA
Recruiting
View on ClinicalTrials.gov →
Summary
Changes in taste and smell can occur during chemotherapy treatment. These chemotherapy-related side effects can negatively impact patients' quality of life and diet. The aim of this research is therefore to propose a solution to alleviate these taste and smell disorders. Based on the same principle as rehabilitation proposed for anosmia (loss of smell) related to COVID-19, we hypothesize that olfactory rehabilitation (using the sense of smell) through the odorous properties of essential oils could be effective for chemotherapy-related taste and smell alterations.
Trial Details
NCT Number NCT07041710
Lead Sponsor Médipôle Lyon-Villeurbanne
Conditions Cancer
Enrollment 104 participants
Start Date 2022-08-16
Primary Completion 2026-12-30 (estimated)
Study Completion 2027-07-30 (estimated)
Updated on ClinicalTrials.gov 2025-06-27